Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2014
Use of biguanides to improve response to chemotherapyVlad C Sandulache, Liangpeng Yang, Heath D SkinnerMethods in Molecular Biology (Clifton, N.J.)|May 20, 2014
Evaluating response to metformin/cisplatin combination in cancer cells via metabolic measurement and clonogenic survivalSang Hyeok Woo, Vlad C Sandulache, Liangpeng Yang, et al.Journal of Virology|July 4, 2008
Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycleMeihong Liu, Liangpeng Yang, Ling Zhang, et al.Plos Pathogens|May 10, 2011
NF-κB hyper-activation by HTLV-1 tax induces cellular senescence, but can be alleviated by the viral anti-sense protein HBZHuijun Zhi, Liangpeng Yang, Yu-Liang Kuo, et al.Journal of Virology|January 7, 2011
Complex cell cycle abnormalities caused by human T-lymphotropic virus type 1 TaxLiangpeng Yang, Naoe Kotomura, Yik-Khuan Ho, et al.The Journal of Antimicrobial Chemotherapy|February 20, 2010
Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effectBing Zhai, Henry Zhou, Liangpeng Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2017
BAP1 Is a Novel Target in HPV-Negative Head and Neck CancerXiyou Liu, Manish Kumar, Liangpeng Yang, et al.Journal for Immunotherapy of Cancer|June 26, 2020
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunityDawei Chen, Hampartsoum B Barsoumian, Grant Fischer, et al.Cancers|January 11, 2022
High Plus Low Dose Radiation Strategy in Combination with TIGIT and PD1 Blockade to Promote Systemic Antitumor ResponsesHampartsoum B Barsoumian, Duygu Sezen, Hari Menon, et al.Cancer Immunology Research|April 18, 2020
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung CancerDawei Chen, Hampartsoum B Barsoumian, Liangpeng Yang, et al.Pageof 2